Back to search

University of Ioannina

Συμβολή στην ανάπτυξη νέων συνθετικών υβριδικών μορίων της ταξόλης με αντικαρκινική δράση

Abstract

dc:description

Paclitaxel is the most important anticancer drug used mainly in treatment of breast, lung and ovarian cancer and is being investigated for use as a single agent for treatment of gastrointestinal tract in this work. We present the synthesis of 2’-paclitaxel substituted analogues in which paclitaxel was covalently bound to peptides or as multiple copies to synthetic carriers. Paclitaxel conjugates were synthesized using 2’-halogeno-acetylated paclitaxel derivatives they showed greater solubility in water than paclitaxel and inhibited the proliferation of human breast, prostate and cervical cancer cell lines. Although all synthesized compounds had an antiproliferative activity, the Ac-[Lys-Aib-Cys(CH₂CO-2' paclitaxel)]₄-NH₂ derivative showed improved biological activity in comparison with paclitaxel in cervical and prostate human cancer cells.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papas, Serafim
  • Παπάς, Σεραφείμ

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/21400

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papas, Serafim; Παπάς, Σεραφείμ. Συμβολή στην ανάπτυξη νέων συνθετικών υβριδικών μορίων της ταξόλης με αντικαρκινική δράση. University of Ioannina, 2007. http://hdl.handle.net/10442/hedi/21400